Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,822 | -3,325 | -12,623 | -9,162 | -6,456 |
| Depreciation Amortization | 32 | 16 | 60 | 45 | 30 |
| Accounts receivable | -64 | -179 | 85 | 34 | 3 |
| Other Working Capital | -535 | 6 | -63 | 71 | 604 |
| Other Operating Activity | 831 | 569 | 2,175 | 1,621 | 1,071 |
| Operating Cash Flow | $-5,558 | $-2,913 | $-10,366 | $-7,391 | $-4,748 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -54 | -29 | -116 | -75 | -55 |
| Investing Cash Flow | $-54 | $-29 | $-116 | $-75 | $-55 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,519 | N/A | 2,006 | 1,947 | 2,006 |
| Other Financing Activity | -165 | 0 | -59 | 0 | -67 |
| Financing Cash Flow | $1,354 | $N/A | $1,947 | $1,947 | $1,939 |
| Beginning Cash Position | 12,872 | 12,872 | 21,407 | 21,407 | 21,407 |
| End Cash Position | 8,614 | 9,930 | 12,872 | 15,888 | 18,543 |
| Net Cash Flow | $-4,258 | $-2,942 | $-8,535 | $-5,519 | $-2,864 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,558 | -2,913 | -10,366 | -7,391 | -4,748 |
| Capital Expenditure | -54 | -29 | -116 | -75 | -55 |
| Free Cash Flow | -5,612 | -2,942 | -10,482 | -7,466 | -4,803 |